{"version":"1.0","provider_name":"Times South Africa","provider_url":"https:\/\/timessouthafrica.com","author_name":"TSA","author_url":"https:\/\/timessouthafrica.com\/author\/tsa\/","title":"Zenas BioPharma nomme Simon Lowry, M.D. au poste de directeur m\u00e9dical - Times South Africa","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"3lpj1F9XtW\"><a href=\"https:\/\/timessouthafrica.com\/zenas-biopharma-nomme-simon-lowry-m-d-au-poste-de-directeur-medical\/\">Zenas BioPharma nomme Simon Lowry, M.D. au poste de directeur m\u00e9dical<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/timessouthafrica.com\/zenas-biopharma-nomme-simon-lowry-m-d-au-poste-de-directeur-medical\/embed\/#?secret=3lpj1F9XtW\" width=\"600\" height=\"338\" title=\"&#8220;Zenas BioPharma nomme Simon Lowry, M.D. au poste de directeur m\u00e9dical&#8221; &#8212; Times South Africa\" data-secret=\"3lpj1F9XtW\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"WALTHAM, Mass. et SHANGHAI, Chine, 07 sept. 2022 (GLOBE NEWSWIRE) \u2014 Zenas BioPharma, une soci\u00e9t\u00e9 biopharmaceutique mondiale d\u00e9termin\u00e9e \u00e0 devenir un leader dans le d\u00e9veloppement et la commercialisation de th\u00e9rapies immunitaires pour les patients dans le besoin \u00e0 travers le monde, a annonc\u00e9 aujourd\u2019hui la nomination de Simon Lowry, M.D., au poste de directeur m\u00e9dical [\u2026]"}